Aspen Pharmaceuticals is now one of SA’s top 100 exporters, employing more than 2 000 people at its Port Elizabeth and Cape Town manufacturing plants. And while geographical expansion has been a strategy from the get-go, the group has trod warily when it comes to expanding into China and the US. However, its latest AstraZeneca and GSK transactions provide Aspen with a neat entry into the Chinese market. Aslam Dalvi comments. view article